Filtered By:
Drug: Fortamet
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 7107 results found since Jan 2013.
Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
CONCLUSION: The present data indicate that treatment with SGLT2-I in patients with T2D and NAFLD is associated with improvement of liver steatosis and fibrosis markers and circulating pro-inflammatory and redox status, more than optimizing glycemic control.PMID:36051336 | PMC:PMC9331534 | DOI:10.3748/wjg.v28.i26.3243
Source: World Journal of Gastroenterology : WJG - September 2, 2022 Category: Gastroenterology Authors: Francesco Bellanti Aurelio Lo Buglio Micha ł Dobrakowski Aleksandra Kasperczyk S ławomir Kasperczyk Palok Aich Shivaram P Singh Gaetano Serviddio Gianluigi Vendemiale Source Type: research
